Nicolaides–Baraitser syndrome

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Nicolaides–Baraitser syndrome
File:Nbs hands2.JPG
Synonyms N/A
Pronounce
Specialty Medical genetics
Symptoms Intellectual disability, seizures, distinctive facial features, short stature, sparse hair
Complications N/A
Onset Infancy
Duration Lifelong
Types
Causes Genetic mutation in the SMARCA2 gene
Risks
Diagnosis Clinical evaluation, genetic testing
Differential diagnosis Coffin–Siris syndrome, Cornelia de Lange syndrome
Prevention
Treatment Symptomatic treatment, supportive care
Medication Anticonvulsants for seizures
Prognosis Variable
Frequency Rare
Deaths


Nicolaides–Baraitser syndrome (NBS) is a rare genetic disorder characterized by distinctive facial features, intellectual disability, and various physical abnormalities. The syndrome was first described by P. Nicolaides and M. Baraitser in 1993.

Signs and Symptoms[edit]

Individuals with Nicolaides–Baraitser syndrome typically present with:

Genetics[edit]

Nicolaides–Baraitser syndrome is caused by mutations in the SMARCA2 gene, which plays a role in chromatin remodeling. This gene is located on chromosome 9.

Diagnosis[edit]

Diagnosis of Nicolaides–Baraitser syndrome is primarily based on clinical features and confirmed by genetic testing to identify mutations in the SMARCA2 gene.

Management[edit]

There is no cure for Nicolaides–Baraitser syndrome. Management focuses on treating the symptoms and may include:

Prognosis[edit]

The prognosis for individuals with Nicolaides–Baraitser syndrome varies depending on the severity of symptoms and associated health issues. Lifespan may be reduced in some cases due to complications from seizures or other medical conditions.

See also[edit]

Categories[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.